chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from an office manager, concerning multiple unspecified patients of an unknown gender and age. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On an unspecified dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX23 (dose, frequency, route, lot # and expiration date were not reported) for prophylaxis. The temperature of the PNEUMOVAX23 was 29 °F for a time frame of 1 hour; it was unknown if a previous temperature excursion occurred. No adverse effects were reported and no product quality complaint (PQC) or data logger was involved. This is one of two reports received from the same reporter. Additional information is not expected, as no consent to contact the reporter was granted; Sender's Comments: US-009507513-1704USA006972:
crying episode lasting 30 & 45mins; pt had high pitched cry that mom is not used to hearing; pt had some crying w/the first shots but was much worse w/this vax fever 100.2
heart palpitation; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart palpitation). At the time of the report, PALPITATIONS (heart palpitation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no treatment provided  no concomitant medication given
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Patient had adverse side effect 30 mins after the vaccine administration. Patient had difficulty breathing, rash on the arm where injection was given and it radiating out to the forearm. Patient managed the adverse effects by taking benadryl. Upon doctor's visit medrol dose pak was prescribed. Advese effects are under control.
Swollen throat, hives on neck, red blisters on back of throat, headache.
PATIENT WAS GIVEN A FLUZONE HD AND HAD ALREADY HAD A FLU SHOT AT HER DRS OFFICE THIS SEASON
1st evening of the vaccine I had a severe headache, worse than I have ever had before.  SO bad I had to ice my head.  I have never experienced a headache like that.  The second evening,  severe chills, felt like I was getting sick.
Intense pain in arm followed by joint pain 5 days later I have fever, loss of taste and smell, diarrhea, chills, disorientation, difficulty breathing
HEAT AND SWELLING IN RIGHT ARM. SIGNIFICANT ENOUGH THAT PATIENT CALLED TO REPORT. STILL HAVING DISCOMFORT SEVERAL DAYS LATER THOUGH NOT WORSENING.
Muscle weakness, shortness of breath, ptosis.  Diagnosed with myasthenia gravis. Acetylcholine Receptor antibodies positive. Patient required multiple large doses of IVIG and high-dose prednisone, which she was discharged on.
Uncontrollable chills and fever for almost 24 hours. Dizzy and lightheaded. Weak, tired hurt all over.  Leg and feet cramps. Was afraid to be alone...I was feeling very depressed and just didn't want to be alone. I got the shot the shot in the morning and by 7:30 PM my problems started. 2 days later I am feeling 85% better but still not comfortable. I know that you have the side effects listed, but it is still very scary when you do not have other health issues. I did reach out to my dr. I will NOT be taking the 2nd shot. This reaction is very scary and to be honest not worth it to me.
Immediately upon vaccination patient described feeling 'light headed,' patient was encouraged to remain seated and put his head between legs. After approx 1 minute patient leaned to his right side, so we decided to place him on the floor. Patient alternated between supine and right side. Patient reported feeling nauseas, so he was given an emesis bag. No vomiting occurred, but there was a fair amount of sputum he expelled. He denied any shortness of breath, heart palpitations, or chest tightness. 911 was called after the patient's mother requested we do so. EMS responders evaluated patient, and by the time they were done evaluating (approx 30min later) patient was sitting and talking without any further symptoms/complaints. Patient was offered transport for further evaluation via EMS, both patient and his mother declined.  Patient stayed at pharmacy for several minutes (approx 15) after EMS left.
I received the vaccine on 09/10/21 around 1500 and woke up around 0200 on 09/11/21 with difficulty breathing and felt like my throat was closing. I took two 25mg  tablets of Equate Allergy Relief (off brand benadryl). Symptom passed and returned to bed. No other major symptom since (it is now 0930).
Suspected vaccination failure; shingles; severe pain; rash; This case was reported by a physician via sales rep and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and rash. On an unknown date, the outcome of the vaccination failure, shingles, pain and rash were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, pain and rash to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2 doses of Shingrix vaccine and had shingles. The reporter stated that, the vaccine was working and doing its job, however, when the patient developed shingles in rare instance after vaccination, it took a very long time and many different tests to determine that the issue was shingles because there was no rash that occurred right away like it typically did for shingles diagnosis. The patient had severe pain and many tests for months before the rash finally occurred and then was diagnosed with Shingles, at this point it was too late to treat. The reporter sated that, Shingles vaccine in cases where there was an outbreak in a patient after vaccination, prolonged diagnosis of actual Shingles. This case was considered as suspected vaccination failure, since the details regarding time to onset for event was not provided.    The reporter did not consent to follow-up. This case has been linked to US2022AMR049400, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR049400:Same reporter
Dose administered after 30-day Use By Date or after Manufacturer Date of Expiry; No AEs were reported; HCP stated that in one of their facilities they accidentally administered 2 doses on 01JUN2023 after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP stated that in one of their facilities they accidentally administered 2 doses on 01JUN2023 after the expiration date.), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after Manufacturer Date of Expiry) and NO ADVERSE EVENT (No AEs were reported) in a 26-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057A22A) for COVID-19 prophylaxis.     Patient relevant medical history/conditions, allergy, concomitant diseases and risk factor were unknown.     On 01-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 01-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP stated that in one of their facilities they accidentally administered 2 doses on 01JUN2023 after the expiration date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after Manufacturer Date of Expiry) and NO ADVERSE EVENT (No AEs were reported). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP stated that in one of their facilities they accidentally administered 2 doses on 01JUN2023 after the expiration date.), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after Manufacturer Date of Expiry) and NO ADVERSE EVENT (No AEs were reported) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No AEs were reported) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (HCP stated that in one of their facilities they accidentally administered 2 doses on 01JUN2023 after the expiration date.) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after Manufacturer Date of Expiry).    Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter.  Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-728181 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-728181:same reporter
This is a spontaneous report from a contactable nurse via a Pfizer Vaccines representative. A 17-year-old female patient of an unspecified ethnicity received TRUMENBA, via an unspecified route of administration, on 07Mar2016, at single dose, and MENACTRA, via an unspecified route of administration in the arm, on 07Mar2016, at 1 DF single. The patient's medical history and concomitant medications were not reported. Previously the patient received HPV vaccine (unspecified trade name) a year before, and experienced similar symptoms. Almost immediately after receiving vaccines the patient experienced did not feel well, general body aches, extreme fatigue and loss of appetite. She generally did not feel well and did not want to get out of bed the next morning. Outcome was unknown. Follow-up (05May2016): Follow-up attempts completed. No further information expected.
Heart arrhythmia from 01:30AM to 04:00AM on 11/22/2021.
Patient went drinking and got a prostitute and had sex. He hadn't had been in 24 years of marriage.
achy arm/hands began hurting; chills; was tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (achy arm/hands began hurting), CHILLS (chills) and FATIGUE (was tired) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     Concomitant products included TIZANIDINE for an unknown indication.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (achy arm/hands began hurting), CHILLS (chills) and FATIGUE (was tired). At the time of the report, PAIN IN EXTREMITY (achy arm/hands began hurting), CHILLS (chills) and FATIGUE (was tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication: OTC allergy medications.  Treatment information was not provided.   This case was linked to MOD-2021-281085 (Patient Link).
Patient received vaccine, went to sit down. After around 5-10 minutes became unconsious and suspected fainting
After receiving the first dose of Pfizer vaccine, the patient walked over to the observation area and fell from standing to  the floor and hit back of head on floor.  When medical personnel approached, the patient's eyes were open and he tried to get up from the floor.  Answering questions appropriately.  A neuro assessment was performed (PERL), oriented x3, equal grasps, 911 was called.  Transported to local ED with mother.
Varicella vaccine breakthrough.  Had varicella vaccine on 8-27-97 and 10-4-07.  Diagnosed with varicella in office on 1-2-08.  Had 20 vesicles & papules.  No fever.
Extremely stiff neck on the third day after vaccine received. Still very stiff and uncomfortable now, day 5 of symptom.
Received vaccines that morning and upon waking from nap at 4:30PM was noted to have hive like rash to left arm, both legs, abdomen, chest and back.  Rash was worse to the left arm where he received the MMR and Varicella vaccine.
5-10 mins post injection patient developed red rash on inner aspects of both arms and neck. Red, warm area developed on left upper arm area extending to elbow. No SOB or tightness in chest noted. Cool pack was applied to left arm. Others that was present felt was an allergic response and advised no further doses of vaccine. Patient reports today that stiffness and rash on left arm is still present. Has sought consult with private medical provider.
Patient fainted upon injection.  Held patient up until regained consciousness (less than 1 minute.   Had patient lay on back with legs elevated for about 5 minutes .  Patient drank water and was fully recovered after 10 minutes and received another immunization.
This spontaneous report has been received from a registered nurse referring to a 6 year old female patient who was with no pertinent medical history or drug reactions/allergies. On 23-SEP-2010 the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX (dose, route and lot# not reported). On 16-OCT-2013 the patient was vaccinated with the second dose of (Oka/Merck) VARIVAX (dose and route not reported, Lot J005429, Expiration date unspecified). There was no concomitant medication. On 18-DEC-2015 the patient developed chicken pox. The patient was seen in the office on 18-DEC-2015 and presented with spots, multiple lesions that appeared to be chickenpox. There was no treatment. The outcome of the patient was reported as not recovered/not resolved. Causality was not reported. This is one of the two reports from the same reporter. Additional information has been requested.
This spontaneous report was received from a nurse and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant therapies was provided. On 23-NOV-2015, the patients were vaccinated with improperly stored doses of oral, ROTATEQ (lot # L006184 and expiration date 13-DEC-2016, lot # reported as L008051 and expiration date 17-NOV-2016, lot # L008057 and expiration date 01-DEC-2016, exact doses were not reported, route of administration defaulted to oral). It was unknown which of the lots of the vaccine were administered on that date, so all lots for the product were listed. No adverse events were reported. No PQC (product quality complaint) was involved. This is one of several reports received from the same source. Additional information has been requested.
It started with a familiar reaction and that was I had tingling and pain in my feet it started with both feet and it was significant, like when the feet goes to sleep and it is coming back and you feel the pins and needles feeling, and it was exactly what I get with CIDP. It moved from both feet up to both hands and I was not really afraid because that is what happens with CIDP when your auto immune system is stimulated. I get numbness on my feet and in my hands. I thought that the vaccine stimulated my immune system. The CIDP has been in remission and maybe the shot has stimulated my nervous system.  The other day I noticed that when taking the hot plate from the microwave it was hot but I did not feel it at all. I thought the food has not heated up, when my wife touched the plate she said it was very hot and I did not feel the plate hot at all. I also felt pain in my left foot to a point that I am not ambulatory. The pain is so extreme in my left foot if I try to stand up. I have been in my bed for the last 2 days. I am not sure if it is the CIDP or GOUT that is attacking my foot but it has been triggered by the vaccine. I also have severe pain in my left leg. I called my cardiologist and I have a phone consultation with him today to check for clot formation. The pain has subsided a bit today, but yesterday the pain in my leg was very intense. I also had pain at the injection site and felt a little feverish since yesterday around 3PM and it went to 101F and this morning I am fine again. I did not take anything for it and this morning I woke up and I felt well (in regards to the fever). I did not have fever before then.
Initial report received from the consumer (patient's father) on 09 Dec 2009: The patient received S-OIV FLUVIRIN 0.5 ml intramuscular vaccination on 05 Dec 2009. On 07 Dec 2009, the patient experienced nausea, diarrhea and abdominal pain. The outcome of diarrhea was reported to be subsided and the outcome of nausea and abdominal pain was reported to be ongoing.
pt recvd vax & exp heat related injuries during physical therapy run during run; lost consciousness & had a rectal t of 107.1; admitted to IC; sxs resolved;
Evening on Monday the 8, I wasn't feeling well. In bed 7p. During that night and all day Tues I had chills, aches, pains, even my hair hurt. Stayed in bed all day Tuesday, up for a bowl of soup, back to bed. I didn't vomit but was too sick to go anyplace. Wednesday morning I was fine, like nothing happened. What a turn around. I had no reaction to the first 2 shots. Just know I will not get another booster.
Reaction that looked like a sunburn and then blistered; Redness; Rash; Sunburn like reaction; First dose of Shingrix 2 years ago; This case was reported by a nurse via sales rep and described the occurrence of blister in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced blister, erythema, rash, sunburn-like rash and incomplete course of vaccination. On an unknown date, the outcome of the blister, erythema, rash, sunburn-like rash and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the blister, erythema, rash and sunburn-like rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccinationwas not reported for 1st dose. The age at vaccination was not applicable for this report for 2nd dose. The patient received 1st dose on an unknown arm. The reporter stated that, thye patient received 1st dose of Shingrix 2 years ago and experienced reaction that looked like a sunburn and then blistered and redness and rash on vaccine arm. Till the trime of reporting, the patient did not receive dose 2 of Shingrix, which led to incomplete course of vaccination. The provider was unsure if the patient should recommend getting the second dose to complete the series. The reporter stated that, patient cut grass in the sun the day after received her first dose of Shingrix.
R arm pain and rash c/w shingles upper arm and thumb. Rx. NEURONTIN.
Extreme pain in left shoulder/arm resulting in the inability to move my arm.  My shot was given right below the shoulder joint rather than a little lower in the muscle, like all other shots I've ever been given.  It's been a week since my 2nd covid shot and I still have nerve pain that goes to the base of my neck and all the way down my arm into my hand at times.  Though it isn't as excrutiating  as a week ago, I still have muscle pain and nerve pain in the shoulder and arm.
Pt recvd MMR vax on 30JAN89 & on 25JAN92 presented to MD w/cough, congestion & earache; dx w/URI & OM; pt tx w/Amoxil; 28JAN92 pt devel a rash & returned to MD; 1FEB92 showed a typical measles picture;
Patient received his vaccine and post-15 minutes, he stated he felt dizzy and sat in the chair in the pharmacy waiting area for 40 minutes. Patient took a dose of Meclizine 25 mg with some water and applied some cold compresses to his face.
vaccines with the adjuvant only; vaccines with the adjuvant only; This case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. A healthcare provider at the doctor's office gave with only MenCYW-135 liquid component without reconstituting which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  They took inventory the day before the day of reporting and had MenA lyophilized (powder) was left.  They were not sure which patients received full dose and which patients received the adjuvant only. They stated that, all the patients that received Shingrix during this week would have to get revaccinated.  The doctor's office reported this to CDC.  No other information was available.  This was 1 of 5 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR178145:same reporter US-GLAXOSMITHKLINE-US2021AMR178137:same reporter US-GLAXOSMITHKLINE-US2021177375:same reporter
Tues 5/18 - First 48 hours achy,  Weds-Thurs 7/18 - 48-72 hours exponentially better.  After 72 hours I was exercising (running) - Friday (run), Sat light exercise, Sunday run.  Monday night 5/24 achy, chills.  Tues 5/25 exhaustion, head and neck pain (moderate), whole body pain (my hands and feet ached while lying there), congestion back of throat / sore throat, low grade fever / chills off and on 5/25 - 5/27.  Negative Covid test 6/3.  It took me two weeks to recover being sick.  A month before I started exercising again.   I thought it worth reporting to VAERS because I just learned that  my brother - who completed his second Pfizer dose - and is experiencing similar timing and symptoms - although he has more gastro issues than I did.  He received his second vaccination 7/9,   Was a bit achy first 48 hours, then fine (exercising as well), then adverse effects 7/14 (ongoing now).  He will be getting a Covid test as well.  We are not in physical contact for 198 months of pandemic.
We inadvertently administered Pfizer to a patient who previously received the Moderna vaccine 7/9/21. Patient was informed and counseled and has not noticed any adverse effects as of yet.
Follow up: Patient received casirivimab instead of intended COVID vaccine.  At 48-hr follow up, patient reported arm soreness.  Patient received COVID vaccine on December 31